Annual Operating Expenses
$234.06 M
-$1.90 M-0.80%
December 31, 2024
Summary
- As of March 12, 2025, ARCT annual total operating expenses is $234.06 million, with the most recent change of -$1.90 million (-0.80%) on December 31, 2024.
- During the last 3 years, ARCT annual operating expenses has risen by +$18.85 million (+8.76%).
- ARCT annual operating expenses is now -0.80% below its all-time high of $235.95 million, reached on December 31, 2023.
Performance
ARCT Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$54.39 M
+$4.84 M+9.77%
December 31, 2024
Summary
- As of March 12, 2025, ARCT quarterly total operating expenses is $54.39 million, with the most recent change of +$4.84 million (+9.77%) on December 31, 2024.
- Over the past year, ARCT quarterly operating expenses has stayed the same.
- ARCT quarterly operating expenses is now -18.94% below its all-time high of $67.10 million, reached on June 30, 2024.
Performance
ARCT Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
ARCT Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.8% | 0.0% |
| 3 y3 years | +8.8% | +8.4% |
| 5 y5 years | +405.5% | +8.4% |
ARCT Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -0.8% | +20.9% | -18.9% | +40.9% |
| 5 y | 5-year | -0.8% | +405.5% | -18.9% | +349.2% |
| alltime | all time | -0.8% | >+9999.0% | -18.9% | +915.0% |
Arcturus Therapeutics Holdings Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $234.06 M(-0.8%) | $54.39 M(+9.8%) |
| Sep 2024 | - | $49.55 M(-26.2%) |
| Jun 2024 | - | $67.10 M(+6.5%) |
| Mar 2024 | - | $63.01 M(+45.4%) |
| Dec 2023 | $235.95 M(+21.9%) | $43.35 M(-30.9%) |
| Sep 2023 | - | $62.69 M(-3.5%) |
| Jun 2023 | - | $64.94 M(-0.1%) |
| Mar 2023 | - | $64.97 M(+68.3%) |
| Dec 2022 | $193.58 M(-10.1%) | $38.60 M(-23.1%) |
| Sep 2022 | - | $50.18 M(+2.0%) |
| Jun 2022 | - | $49.18 M(-11.6%) |
| Mar 2022 | - | $55.62 M(+28.0%) |
| Dec 2021 | $215.21 M(+165.5%) | $43.44 M(-22.8%) |
| Sep 2021 | - | $56.26 M(+1.0%) |
| Jun 2021 | - | $55.72 M(-6.8%) |
| Mar 2021 | - | $59.79 M(+79.5%) |
| Dec 2020 | $81.06 M(+75.1%) | $33.32 M(+43.2%) |
| Sep 2020 | - | $23.27 M(+88.2%) |
| Jun 2020 | - | $12.36 M(+2.1%) |
| Mar 2020 | - | $12.11 M(-12.2%) |
| Dec 2019 | $46.30 M(+23.3%) | $13.79 M(+26.1%) |
| Sep 2019 | - | $10.93 M(+1.9%) |
| Jun 2019 | - | $10.72 M(-1.2%) |
| Mar 2019 | - | $10.86 M(+31.0%) |
| Dec 2018 | $37.56 M | $8.29 M(+6.5%) |
| Sep 2018 | - | $7.78 M(-37.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $12.46 M(+37.8%) |
| Mar 2018 | - | $9.04 M(+29.4%) |
| Dec 2017 | $23.49 M(+9.9%) | $6.99 M(+9.0%) |
| Sep 2017 | - | $6.41 M(+32.8%) |
| Jun 2017 | - | $4.83 M(+32.9%) |
| Mar 2017 | - | $3.63 M(+57.4%) |
| Dec 2016 | $21.38 M(+165.6%) | $2.31 M(-70.9%) |
| Sep 2016 | - | $7.92 M(+33.9%) |
| Jun 2016 | - | $5.92 M(+13.1%) |
| Mar 2016 | - | $5.23 M(-178.4%) |
| Dec 2015 | $8.05 M(-75.7%) | -$6.67 M(-254.4%) |
| Sep 2015 | - | $4.32 M(-16.4%) |
| Jun 2015 | - | $5.17 M(-1.1%) |
| Mar 2015 | - | $5.23 M(-23.4%) |
| Dec 2014 | $33.08 M(+221.5%) | $6.83 M(-35.5%) |
| Sep 2014 | - | $10.59 M(+35.2%) |
| Jun 2014 | - | $7.83 M(-0.1%) |
| Mar 2014 | - | $7.83 M(+38.8%) |
| Dec 2013 | $10.29 M(+585.5%) | $5.64 M(+80.0%) |
| Sep 2013 | - | $3.14 M(+162.2%) |
| Jun 2013 | - | $1.20 M(+280.9%) |
| Mar 2013 | - | $314.00 K(+26.1%) |
| Dec 2012 | $1.50 M(-61.6%) | $249.00 K(-5.7%) |
| Sep 2012 | - | $264.00 K(-38.5%) |
| Jun 2012 | - | $429.00 K |
| Dec 2011 | $3.91 M | - |
FAQ
- What is Arcturus Therapeutics Holdings annual total operating expenses?
- What is the all time high annual operating expenses for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings annual operating expenses year-on-year change?
- What is Arcturus Therapeutics Holdings quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings quarterly operating expenses year-on-year change?
What is Arcturus Therapeutics Holdings annual total operating expenses?
The current annual operating expenses of ARCT is $234.06 M
What is the all time high annual operating expenses for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high annual total operating expenses is $235.95 M
What is Arcturus Therapeutics Holdings annual operating expenses year-on-year change?
Over the past year, ARCT annual total operating expenses has changed by -$1.90 M (-0.80%)
What is Arcturus Therapeutics Holdings quarterly total operating expenses?
The current quarterly operating expenses of ARCT is $54.39 M
What is the all time high quarterly operating expenses for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high quarterly total operating expenses is $67.10 M
What is Arcturus Therapeutics Holdings quarterly operating expenses year-on-year change?
Over the past year, ARCT quarterly total operating expenses has changed by $0.00 (0.00%)